The Gloucester vessel sank off Cape Ann on Jan. 30, killing all seven crew members. Six bodies remain unrecovered as harsh ...

State Senator Bruce Tarr said the investigation into the sinking has entered its “next phase” and officials hope to provide families “with the kind of information they need to even begin to approach ...

The centerpiece is Big Seven Lake, a sprawling 137-acre aquatic playground that makes you forget you’re in southeastern Michigan and not some remote wilderness retreat. Approaching the park entrance ...

30 days of a water lily rhizome sprouting and growing lily pads. A key nuclear weapons treaty is ending. It’s a blow to Russia’s ‘superpower’ myth Wegovy maker warns of 'painful' price cuts as shares ...

Hims & Hers Health began advertising a $49 Ozempic pill lookalike last week -- then stopped. Novo Nordisk charges $149 for its own Wegovy pills. Lilly charges $299 for Zepbound shots. First, on Friday ...

For Evangeline Lilly, the road to recovery doesn't have to be lonely. The Golden Globe-nominated actress, who has been navigating a traumatic brain injury, opened up about her recovery efforts in an ...

Eli Lilly has been a growth beast and its top line may soar by as much as 27% this year. Novo Nordisk is bracing for a potential double-digit decline in sales, as it tries to fight off copycat ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Eli Lilly and Co. is buying a ...

Eli Lilly (LLY) has agreed to acquire biotechnology company Orna Therapeutics for up to $2.4B in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain clinical ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Matthew Herper covers medical innovation — both its promise and its perils. Eli Lilly will pay up to $2.4 billion to acquire Orna Therapeutics, a biotechnology firm that is developing a technology to ...